Astana Biomed Group, an authorized Abcam distributor in Central Asia

Kinases

Erlotinib hydrochloride, EGFR tyrosine kinase inhibitor (ab141930)

Description:
Potent EGFR tyrosine kinase inhibitor
Application:
Reactivity:
Conjugate:

Gefitinib, EGFR tyrosine kinase inhibitor (ab142052)

Description:
Orally active, potent, selective EGFR tyrosine kinase inhibitor
Application:
Reactivity:
Conjugate:

L779450, Raf kinase inhibitor (ab120837)

Description:
Potent Raf kinase inhibitor
Application:
Reactivity:
Conjugate:

Lestaurtinib, JAK2, FLT3 and TrkA receptor tyrosine kinase inhibitor (ab142107)

Description:
Potent JAK2, FLT3 and TrkA receptor tyrosine kinase inhibitor
Application:
Reactivity:
Conjugate:

NVP-TAE684, ALK inhibitor (ab142082)

Description:
Highly potent, selective ALK inhibitor
Application:
Reactivity:
Conjugate:

SB 505124, ALK5 inhibitor (ab144402)

Description:
Potent, reversible, competitive ALK5 inhibitor
Application:
Reactivity:
Conjugate:

AS601245, JNK inhibitor (ab145194)

Description:
Potent, selective, ATP competitive JNK inhibitor. Cell-permeable.
Application:
Reactivity:
Conjugate:

D-Sphingosine, protein kinase C inhibitor (ab142297)

Description:
Potent specific protein kinase C inhibitor
Application:
Reactivity:
Conjugate:

Dabrafenib,  mutant B-Raf V600E inhibitor (ab222019)

Description:
Potent mutant B-Raf V600E inhibitor
Application:
Reactivity:
Conjugate:

Human ARAF knockout A-431 cell line (ab276086)

Description:
ARAF KO A-431 cell line
Application:
Reactivity:
Conjugate:
© 2021 Astana Biomed Group LLP. All rights reserved.